Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IA versus intensive DA induction chemotherapy for de novo acute myeloid leukemia
ChiCTR-TRC-11001482Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jul 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of idarubicin, daunorubicin and cytarabine in acute myeloid leukemia (AML) (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: complete remission. Started Jul 2011; status: recruiting.
02
Drugs
idarubicindaunorubicincytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on ChiCTR-TRC-11001482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001482.